MYELOPROLIFERATIVE NEOPLASMS (MPN)
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS (MPN) explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS (MPN) trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS (MPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare blood cancers in early trial
Disease control Recruiting nowThis study tests a new daily pill called JBI-802 in people with certain blood cancers (myeloproliferative neoplasms and MDS/MPN) who have too many platelets. The trial has two phases: first, finding a safe dose in about 30 adults, then checking if it works. Participants take the …
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPN)
Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Tailored exercise may ease symptoms of rare blood cancer
Symptom relief Recruiting nowThis study tests whether a 3-month personalized exercise program can improve quality of life, fitness, and symptoms in people with myeloproliferative neoplasms (MPN), a group of rare blood cancers. About 80 participants will be randomly assigned to either start the exercise progr…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPN)
Phase: NA • Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC